[PubMed] [CrossRef] [Google Scholar] 50. GRK2 proteins. To evaluate the effects of GRK2 on mitochondrial respiration, we generated stable myoblast lines that overexpress GRK2. Stable overexpression of GRK2 resulted in increased mitochondrial content and enhanced mitochondrial/oxidative respiration. Interestingly, although overexpression of GRK2 was unable to prevent myostatin-mediated impairment of mitochondrial respiratory function, elevated levels of GRK2 blocked the increased autophagic flux observed following treatment with myostatin. Overall, our data suggest a novel role for GRK2 in regulating mitochondria mass and mitochondrial respiration in skeletal muscle mass. (62) and was used at a concentration of 3 g/mL for cell treatments, unless otherwise stated. For proteasome inhibitor studies, C2C12 myotubes were treated with 3 g/mL recombinant Mstn for a total period of 24 h. To block the activity of the proteasome, MG132 (Sigma, St. Louis, MO) and epoxomicin (Epox; Sigma) chemicals were added to C2C12 myotubes at 10 M and 100 nM final concentrations, respectively, 10 h prior to PF 573228 harvesting the cells. The difference in total GRK2 seen in the absence of presence of the proteasome inhibitors represents the content of GRK2 that is being degraded through the ubiquitin-proteasome PF 573228 system (29, 34). One impartial experiment was performed with MG132 with three biological replicates, and one confirmatory experiment PF 573228 was performed with Epox. To block the lysosomal pathway, 100 M Rabbit Polyclonal to p42 MAPK of chloroquine (Sigma) were added to myotubes in the presence or absence of Mstn (3 g/mL) for 12 h. The difference in the protein levels of LC3-II between samples treated with and without chloroquine represents the level of autophagic flux in the cells (30, 77). Two different experiments were performed, each with one biological replicate. Generation of GRK2 stable cell lines. Full-length murine cDNA (“type”:”entrez-nucleotide”,”attrs”:”text”:”NM_130863″,”term_id”:”595763201″,”term_text”:”NM_130863″NM_130863.2) was PCR amplified using the following primers: 5-CC ACC GGT ATG CAG AAG TAT CTG GAG GAC CGA-3 and 5-ACC TGT ACA TCA GAG GCC GTT GGC Take action GCC ACG-3 and cloned into the pGEM-T easy cloning vector (Promega). After sequence verification, was subcloned into the doxycycline-inducible PEM777 expression vector (28). oxidase I; oxidase II; oxidase III; for 1 min. Cell pellets were resuspended in PBS, and FACS analysis was performed to detect MitoTracker Green FM fluorescence intensity using the FACSCanto II circulation cytometry system (BD Biosciences, Franklin Lakes, NJ). Fluorescent intensity of 10,000 events from 3 replicate wells per experimental group was detected using the FITC channel and is represented as mean fluorescent intensity. Two technical replicates were performed. Statistical analysis. Statistical analysis was performed using two-tail Students 0.05. A description of experiment replicates is provided in relevant physique legends. RESULTS Mstn promotes the loss of GRK2 protein via the ubiquitin proteasome pathway. In the beginning we investigated whether or not myostatin can modulate GRK2 expression. Immunoblot (IB) analysis revealed PF 573228 that treatment of C2C12 myotubes with recombinant myostatin protein (Mstn) resulted in a ~70% decrease in GRK2 protein content after 24-h treatment (Fig. 1and and ?anddensitometric analysis of protein levels (GRK2) normalized to GAPDH levels. Values symbolize means??SE; 5 biological replicates from 3 impartial experiments were performed and analyzed; * 0.05 (Students = 3 biological replicates from one independent experiment. and and mRNA expression, in GRK2-overexpressing C2C12 myotubes (Fig. 2, and expression in stable Control and GRK2-overexpressing C2C12 myotubes treated with (+) or without (?) myostatin (Mstn) for 24 h. Gene expression was normalized to the endogenous control = 3 biological replicates from one impartial experiment; * 0.05 vs. Control ? Mstn; # 0.05 vs. GRK2 ? Mstn. One-way ANOVA with Bonferroni correction was utilized for multiple comparisons. = 3 biological replicates from 1 impartial experiment. * PF 573228 0.05 vs. Control ? Mstn; # 0.05 vs. GRK2 ? Mstn; & 0.05 vs. Control + Mstn. One-way ANOVA with Bonferroni correction was utilized for multiple comparisons. oxidase I (oxidase II.